A Case-Based Approach to Targeted Therapy with COTELLIC (cobimetinib) and ZELBORAF (vemurafenib) for BRAFV600E/K Mutation-Positive Unresectable or Metastatic Melanoma

Written by patrippon on August 10, 2017.

When

08/10/17

6:00 pm - 8:00 pm

Where

Fleming's Prime Steakhouse and Wine Bar
180 El Camino Real, Palo Alto, CA, 94304

Loading Map....

This clinical presentation is designed for oncology nurses who may help treat patients with COTELLIC and ZELBORAF and will review clinical data and safety profile information.

Presented by:
Grace Cherry, MSN
Nurse Practitioner
UCLA Oncology
Los Angeles, CA